AstraZenaca shareholder speaks out

In this video

Share

AstraZenaca shareholder speaks out

Martin Gilbert, Aberdeen Asset Management CEO, explains why he opposed Pfizer's initial bid for AstraZenaca.
00:43
Wed, May 21 20141:30 PM EDT